Benzinga | Feb 25, 2021 04:05PM EST

Cara Therapeutics Q4 EPS $1.59 May Not Compare To $0.36 Estimate, Sales $112.09M May Not Compare To $48.63M Estimate

Cara Therapeutics (NASDAQ:CARA) reported quarterly earnings of $1.59 per share which beat the analyst consensus estimate of $0.36 by 341.67 percent. This is a 360.66 percent increase over losses of $(0.61) per share from the same period last year. The company reported quarterly sales of $112.09 million which beat the analyst consensus estimate of $48.63 million by 130.49 percent. This is a 2.38K percent increase over sales of $4.51 million the same period last year.